SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
22.29
-0.32 (-1.42%)
Mar 30, 2026, 9:51 AM EDT - Market open
SpyGlass Pharma Market Cap
SpyGlass Pharma has a market cap or net worth of $742.65 million as of March 30, 2026.
Market Cap
742.65M
Enterprise Value
647.45M
1-Year Change
n/a
Ranking
Category
Stock Price
$22.29
Market Cap Chart
Since the IPO on February 6, 2026, SpyGlass Pharma's market cap has increased from $510.58M to $742.65M, an increase of 45.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 753.31M | -10.28% |
| Mar 26, 2026 | 839.60M | -0.08% |
| Mar 25, 2026 | 840.27M | 6.23% |
| Mar 24, 2026 | 790.96M | -9.91% |
| Mar 23, 2026 | 877.91M | 1.35% |
| Mar 20, 2026 | 866.25M | 1.13% |
| Mar 19, 2026 | 856.59M | -4.07% |
| Mar 18, 2026 | 892.91M | -1.47% |
| Mar 17, 2026 | 906.23M | 0.37% |
| Mar 16, 2026 | 902.90M | 2.07% |
| Mar 13, 2026 | 884.58M | 0.49% |
| Mar 12, 2026 | 880.25M | -2.51% |
| Mar 11, 2026 | 902.90M | 1.04% |
| Mar 10, 2026 | 893.57M | -1.11% |
| Mar 9, 2026 | 903.57M | 1.65% |
| Mar 6, 2026 | 888.91M | 0.98% |
| Mar 5, 2026 | 880.25M | -0.97% |
| Mar 4, 2026 | 888.91M | -0.26% |
| Mar 3, 2026 | 891.24M | 0.07% |
| Mar 2, 2026 | 890.57M | -4.54% |
| Feb 27, 2026 | 932.89M | -1.23% |
| Feb 26, 2026 | 944.55M | -2.68% |
| Feb 25, 2026 | 970.54M | -0.55% |
| Feb 24, 2026 | 975.87M | -0.20% |
| Feb 23, 2026 | 977.87M | 0.10% |
| Feb 20, 2026 | 976.87M | -1.21% |
| Feb 19, 2026 | 988.86M | 4.14% |
| Feb 18, 2026 | 949.55M | 2.93% |
| Feb 17, 2026 | 922.56M | -1.88% |
| Feb 13, 2026 | 940.22M | 2.62% |
| Feb 12, 2026 | 916.23M | -0.18% |
| Feb 11, 2026 | 917.89M | -1.01% |
| Feb 10, 2026 | 927.22M | 6.30% |
| Feb 9, 2026 | 872.25M | 70.84% |
| Feb 6, 2026 | 510.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ARS Pharmaceuticals | 801.33M |
| Evommune | 798.89M |
| Aktis Oncology | 797.81M |
| SELLAS Life Sciences Group | 783.88M |
| Cullinan Therapeutics | 777.76M |
| Theravance Biopharma | 776.51M |
| Tenax Therapeutics | 749.48M |
| Annexon | 745.28M |